Director
DIN: 09295007
Chandana Jagadeesh is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at BEL RAM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09295007. Chandana Jagadeesh is currently involved in 3 different roles. Their most recent position is with BELRAM BIOLOGICS PRIVATE LIMITED as a Director. The first company Chandana Jagadeesh was appointed to as a director was BEL RAM PHARMACEUTICALS PRIVATE LIMITED. Chandana Jagadeesh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Chandana Jagadeesh is currently associated with 2 companies in various capacities such as Additional Director, Director and Individual Promoter. They serve as a Director at BEL RAM PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09295007. Chandana Jagadeesh is currently involved in 3 different roles. Their most recent position is with BELRAM BIOLOGICS PRIVATE LIMITED as a Director. The first company Chandana Jagadeesh was appointed to as a director was BEL RAM PHARMACEUTICALS PRIVATE LIMITED. Chandana Jagadeesh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1 Year 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BEL RAM PHARMACEUTICALS PRIVATE LIMITED | Additional Director | 26-Aug-2021 |
| BELRAM BIOLOGICS PRIVATE LIMITED | Director | 28-Jun-2022 |
| BELRAM BIOLOGICS PRIVATE LIMITED | Individual Promoter | 28-Jun-2022 |